Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy
NCT00984802
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
Stable Coronary Artery Disease
Percutaneous Coronary Intervention
Interventions
DRUG:
CMX-2043
DRUG:
Placebo control
Sponsor
Ischemix, LLC